Invetx Announces $15 Million Series A Financing and Industry-leading Partnerships for Animal Biopharmaceutical Development
Feb 24, 2020•over 5 years ago
Amount Raised
$15 Million
Round Type
series a
Description
Invetx, a pioneering animal health biopharmaceutical company, today announced a $15 million Series A financing and founding collaborations with WuXi Biologics and AbCellera. The financing was led by Invetx’s founding investor, Anterra Capital, and will drive clinical entry of a first therapeutic candidate and preclinical development of Invetx’s broader pipeline of protein-based therapeutics. With this financing, the leading global biologics CDMO WuXi Biologics joins Invetx as an investor and a research collaborator.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech